Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > And, this is Doug Loe....
View:
Post by rgonlyfactspls on Mar 04, 2015 1:20pm

And, this is Doug Loe....

Douglas Loe, healthcare equity analyst with Euro Pacific Canada, brings more than a decade of experience to financial analysis in the global drug development, medical technology, healthcare services and specialty pharmaceutical sectors. Loe has been recognized as one of Canada's top healthcare analysts by the StarMine Analysts Awards, based on the quality of his recommendations to institutional investors. With his extensive knowledge of the healthcare industry, Loe analyzes and publishes his views on trends in the sector and interprets them within the context of a diversified suite of companies under coverage, many of which locked in substantial returns for investors over the last several quarters. He holds a Ph.D. in biochemistry. - https://www.thelifesciencesreport.com/pub/htdocs/expert.html?id=8865 -- Hopefully we will read more about his views and projection in an upcoming Streetwise Reports: The Life Sciences Report. Or, just a thought...on Telesta's website.
Comment by DamnYankees on Mar 04, 2015 4:47pm
Rfacts,  do you have a link to the report. 1.25 seems super conservative. But it could serve as a framework for a buyout especially if it is reputable coverage which It looks like it is based on a simple Google search.
Comment by loveshackdave on Mar 04, 2015 4:56pm
As a 12 month estimate, it's not that conservative. Telesta probably won't have FDA approval by then.
Comment by wussy on Mar 04, 2015 8:02pm
The shorts are getting nervous? T : TST 2015-02-28 698,700 4,000 168,485,545 0.41 T : TST 2015-02-15 694,700 180,000 167,966,200 0.41 T : TST 2015-01-31 514,700 475,200 167,966,200 0.31 T : TST 2015-01-15 39,500 19,500 167,854,018 0.02 T : TST 2014-12-31 20,000 -25,500 167,854,018 0.01 T : TST 2014-12-15 45,500 45,500 167,739,008 0.03 V : TST 2005-11-30 0 -490 GLTA Wussy
Comment by loveshackdave on Mar 04, 2015 9:27pm
Are there any? Can. You even short this stock of you wanted to? Even if you could, it moves way to slowly to be attractive to shorts IMO. It would be largely ignored.
Comment by DamnYankees on Mar 04, 2015 8:24pm
alright thanks Jack. The person who recommended this company to me has indicated that this analyst and Co. Are very well though of. He also suggested that a deal may already be done and this is the 3rd party justification for the selling price. Possibly I spose but I think it would be nice to actually read it.It would save much delay and back and forth in selling a buyout to sharholders.  The ...more  
Comment by loveshackdave on Mar 04, 2015 9:32pm
Damn that would really suck if the selling price was $1.25 per share. This company is worth so much more than that. If that's the case, it would indicate to me that management just wanted out and all that talk about maximizing shareholder value was just bullshit.
Comment by DamnYankees on Mar 04, 2015 9:57pm
Burying your 104 year uncle that nobody has visited since 1979 sucks too. Management can't get out fast enough Shack. Berendt makes a few mil at $1.25 and Olds pockets a 3rd. That ain't bad for laying off 125 people you have never met and phoning some friends to say some nice things about your new venture. Everybody wins, and now it looks legit, so let's get it done!
Comment by rgonlyfactspls on Mar 05, 2015 12:28pm
"The Life Sciences Report", From Streetwise, is emailed every Thursday aft and usually hits the in-basket between 1pm and 5pm EST. Hoping to see a contribution in this week's report from Douglas Loe re: Telesta. Here is a link to last week's issue (sign-up) and a second link to their impressive list of contributing analysts (which Mr. Loe is included in). - https://editor.des09 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities